Lemaitre Vascular (LMAT) EV to EBITDA (2010 - 2026)

Lemaitre Vascular (LMAT) has reported EV to EBITDA for 17 consecutive years, with 89.12 the latest figure, recorded in Q2 2026.

• On a quarterly basis, EV to EBITDA fell 7.82% year-over-year to 89.12 in Q2 2026; TTM through Jun 2026 was 23.51, a 17.48% decrease from a year earlier, with the FY2025 full-year figure at 21.91, down 35.61% from the prior year.
• EV to EBITDA was 89.12 for Q2 2026 at Lemaitre Vascular, down from 119.67 in the prior quarter.
• Over five years, EV to EBITDA peaked at 168.34 in Q3 2022 and troughed at 79.0 in Q4 2025.
• A 5-year average of 123.18 and a median of 121.13 in 2023 frame the typical range for EV to EBITDA.
• Across the five-year window, EV to EBITDA soared 39.82% in 2022 and plunged 45.89% in 2025, its largest moves.
• Over 5 years, EV to EBITDA stood at 134.09 in 2022, then dropped by 15.04% to 113.93 in 2023, then climbed by 21.41% to 138.32 in 2024, then sank by 42.89% to 79.0 in 2025, then advanced by 12.8% to 89.12 in 2026.
• The last three EV to EBITDA figures came in at 89.12 (Q2 2026), 119.67 (Q1 2026), and 79.0 (Q4 2025), per Business Quant data.